The APP/PS1 double transgenic mouse model is commonly used in studies on cerebral and neurological disorders, especially in AD (Chen C. L. et al., 2022), amyloid plaque formation, and aging (Ordóñez-Gutiérrez et al., 2013). The gene discussed is APP; the disease is nervous system disorder.